1,3-Dimethoxy-cyclopentan | 89794-54-7

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 1,3-Dimethoxy-cyclopentan
• 英文别名: Cyclopentane, 1,3-dimethoxy-, trans-；1,3-dimethoxycyclopentane
• CAS: 89794-54-7
• 化学式: C₇H₁₄O₂
• 分子量: 130.187
• InChiKey: QBRPYJDRWAUJGP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  9
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• Sulfonamide compound
  申请人：Matsubara Koki

  公开号：US20090048223A1

  公开（公告）日：2009-02-19

  A compound represented by the formula (1) [A represents a nitrogen-containing saturated ring; m represents an integer of 0 to 2; n represents an integer of 1 to 4; G 1 represents hydrogen atom, chlorine atom, hydroxyl group, an alkoxy group, or amino group; G 2 represents a halogen atom, hydroxyl group, cyano group, carboxy group, an alkyl group, an alkenyl group, an alkynyl group, an alkoxy group, an alkylthio group, an amino group, an alkylsulfinyl group, an alkylsulfonyl group, or an aryl group; G 3 represents hydrogen atom, a halogen atom, hydroxyl group, cyano group, carboxy group, an alkyl group, an alkenyl group, an alkynyl group, an alkoxy group, an alkylthio group, an amino group, an alkoxycarbonyl group, an acyl group, an acyloxy group, an alkylsulfinyl group, an alkylsulfonyl group, or an aryl group; Y represents a single bond, or —C(R 3 )(R 4 )— (R 3 and R 4 represent hydrogen atom, or an alkyl group, or alkylene groups which combine together to form a saturated hydrocarbon ring group); G 4 represents hydroxyl group (Y is a single group), or —N(R 1 )(R 2 ) (R 1 and R 2 represent hydrogen atom, an alkyl group, an aralkyl group, an alkenyl group, an alkynyl group, a saturated heterocyclic group, an alkylsulfonyl group, an acyl group, or an amidino group); G 5 is a substituent on a ring-constituting carbon atom of A, and represents hydrogen atom, fluorine atom, or an alkyl group] or a salt thereof, or a derivative thereof that is a prodrug, which potently inhibits Rho kinase.

  由以下化学式表示的化合物：[A代表含氮饱和环；m表示0到2的整数；n表示1到4的整数；G1代表氢原子、氯原子、羟基、烷氧基或氨基；G2代表卤原子、羟基、氰基、羧基、烷基、烯基、炔基、烷氧基、烷硫基、氨基、烷氧羰基、酰基、乙酰氧基、烷基磺基、烷基磺酰基或芳基；G3代表氢原子、卤原子、羟基、氰基、羧基、烷基、烯基、炔基、烷氧基、烷硫基、氨基、烷氧羰基、酰基、乙酰氧基、烷基磺基、烷基磺酰基或芳基；Y代表单键，或-C(R3)(R4)-（R3和R4代表氢原子、烷基或烷烯基，它们结合在一起形成饱和碳氢环基）；G4代表羟基（Y是单个基），或-N(R1)(R2)（R1和R2代表氢原子、烷基、芳基、烯基、炔基、饱和杂环基、烷基磺酰基、酰基或胺基）；G5是A的环构成碳原子上的取代基，代表氢原子、氟原子或烷基]或其盐、或作为前药的衍生物，其强力抑制Rho激酶。
• Imidazolium-Methyl Sulfites for Use as Starting Compounds for Producing Ionic Liquids
  申请人：Szarvas Laszlo

  公开号：US20070255064A1

  公开（公告）日：2007-11-01

  Imidazolium methylsulfites of the general formula (I) where the radicals have, independently of one another, the following meanings: R 1 to R 3 : hydrogen, halogen, hydroxy, amino, aminocarbonyl, sulfo, cyano, nitro; C 1 -C 20 -alkyl, C 2 -C 20 -alkenyl, C 2 -C 20 -alkynyl, C 1 -C 20 -alkyloxy, C 2 -C 20 -alkenyloxy, C 2 -C 20 -alkynyloxy, C 1 -C 20 -alkylcarbonyl, C 1 -C 20 -alkyloxycarbonyl, C 1 -C 20 -acyloxy, C 1 -C 20 -alkylaminocarbonyl, di(C 1 -C 20 -alkyl)aminocarbonyl, C 1 -C 20 -alkylamino, di(C 1 -C 20 -alkyl)amino, C 1 -C 20 -alkylsulfonyl, C 3 -C 8 -cycloalkyl, where the alkyl, alkenyl, alkynyl and cycloalkyl groups mentioned can be substituted and/or have their CH 2 groups replaced by oxygen; phenyl, phenoxy, where these can in turn be substituted; R 4 : sulfo; C 1 -C 20 -alkyl, C 2 -C 20 -alkenyl, C 2 -C 20 -alkynyl, C 3 -C 8 -cycloalkyl, where the alkyl, alkenyl, alkynyl and cycloalkyl groups mentioned can be substituted and/or have their CH 2 groups replaced by oxygen; phenyl, where this can be substituted; or R 1 together with R 4 , and/or R 2 together with R 3 , or R 4 together with R 2 : alkylene —(CH 2 ) n — where n=4, 5 or 6 or butadienylene —CH═CH—CH═CH—, where these can be substituted and/or have the CH 2 groups replaced by oxygen and the CH groups replaced by NR 5 .

  通式（I）的咪唑甲基亚磺酸盐，其中基团独立地具有以下含义：R1至R3：氢、卤素、羟基、氨基、氨基甲酰、磺酰、氰基、硝基；C1-C20烷基、C2-C20烯基、C2-C20炔基、C1-C20烷氧基、C2-C20烯氧基、C2-C20炔氧基、C1-C20烷基羰基、C1-C20烷氧羰基、C1-C20酰氧基、C1-C20烷基氨基甲酰、二（C1-C20烷基）氨基甲酰、C1-C20烷基氨基、二（C1-C20烷基）氨基、C1-C20烷基磺酰基、C3-C8环烷基，其中所述的烷基、烯基、炔基和环烷基可以被取代和/或其CH2基团被氧取代；苯基、苯氧基，其中这些可以被取代；R4：磺酰基；C1-C20烷基、C2-C20烯基、C2-C20炔基、C3-C8环烷基，其中所述的烷基、烯基、炔基和环烷基可以被取代和/或其CH2基团被氧取代；苯基，其中这可以被取代；或者R1和R4、R2和R3、或R4和R2一起：烷基链—（CH2）n—，其中n = 4、5或6或丁二烯基链—CH═CH—CH═CH—，其中这些可以被取代和/或其CH2基团被氧取代，CH基团被NR5取代。
• Compounds for Treating Respiratory Syncytial Virus Infections
  申请人：BIOTA SCIENTIFIC MANAGEMENT PTY LTD.

  公开号：US20160046642A1

  公开（公告）日：2016-02-18

  The present invention relates to compounds of formula (I) its salts, isomers or prodrugs thereof useful in the treatment of viral infections, in particular respiratory syncytial virus (RSV) infections. The present invention also relates to processes for preparing the compounds and intermediates used in their preparation.

  本发明涉及式(I)化合物及其盐、异构体或前药，在治疗病毒感染，特别是呼吸道合胞病毒（RSV）感染方面具有用途。本发明还涉及制备这些化合物和其制备中使用的中间体的过程。
• Pyrrole derivatives
  申请人：HUA MEDICINE (SHANGHAI) LTD.

  公开号：US10669255B2

  公开（公告）日：2020-06-02

  Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment or prevention of mGluR5 mediated disorders, such as acute and/or chronic neurological disorders, cognitive disorders and memory deficits, as well as acute and chronic pain.

  本文提供了式(I)化合物及其药学上可接受的盐类，其中的取代基与说明书中公开的相同。这些化合物以及含有它们的药物组合物可用于治疗或预防 mGluR5 介导的疾病，如急性和/或慢性神经系统疾病、认知障碍和记忆缺陷，以及急性和慢性疼痛。
• Pyrrole Derivatives
  申请人：HUA MEDICINE (SHANGHAI) LTD.

  公开号：US20190100506A1

  公开（公告）日：2019-04-04

  Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment or prevention of mGluR5 mediated disorders, such as acute and/or chronic neurological disorders, cognitive disorders and memory deficits, as well as acute and chronic pain.